Skip to content
healthcare.dev
Get a free key

Diltiazem Hydrochloride

NDC 68682-709, Diltiazem Hydrochloride Extended-Release Tablets, tablet, extended release, from Oceanside Pharmaceuticals.

Product NDC
68682-709
Status
Listed
Labeler
Oceanside Pharmaceuticals
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021392
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68682-709 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DILTIAZEM HYDROCHLORIDE420 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]

Package NDCNDC-11Package
68682-709-306868207093030 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-709-30)
68682-709-906868207099090 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-709-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/73b3607a-99d0-44d8-92ef-0074684c9d7d

Use it

Look up 68682-709 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68682-709 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68682-709. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.